Feedback
The current prices are delayed. Login to see live prices.

Divi's Laboratories Ltd.

(DIVISLAB)

70123456789,201234567894012345678980123456789.5012345678900123456789
-56.50 (-0.77%)
Updated 15:59 24/07 IST
Add
Previous Close: 7305
Today's low
₹7,177.00
Today's high
₹7,280
52 week low
₹3,350
52 week high
₹7,438.5
Open
₹7,230
Prev Close
₹7,305
Volume (shares)
328,948
Total Trading Value
240.3 Cr

Technicals

SMA
Value
Signal
12-SMA
5,814.54
Bullish
20-SMA
5,882.13
Bullish
50-SMA
5,862.54
Bullish
100-SMA
5,902.42
Bullish
200-SMA
5,336.81
Bullish

Discussions

  •  May 28 8:34 PM
🚨📊 DIVISLAB Trade Setup
📈 Above 6,900 = Strong Bullish Momentum...read more

1

  •  Jul 17 2:00 AM
🚨 DIVISLAB Trade Setup
📈 Above 7,300 = Bullish...read more

1

1
  •  Jul 14 2:08 AM
  •  Jul 15 3:44 PM
DIVISLAB – BUY
Entry: ₹7,324...read more

1

  •  Apr 14 6:37 PM
💊 Divis Lab – Wave 4 Support, Breakout Soon? 🚀...read more

1

  •  May 20 3:26 PM
Buy Price : 6935...read more

1

  •  Apr 28 2:06 PM
BUY DIVIS LABORATORIES LTD
ABOVE 6468.25...read more

1

  •  Jun 3 12:35 PM
# ADC (Antibody Drug Conjugate) Opportunity in Indian Pharma
STOCK TUTOR...read more

1

Load More Posts

Frequently Asked Questions (FAQs)

What is the Share Price of Divi's Laboratories Ltd. ?

The share prices are volatile and fluctuate throughout the trading hours. The share price of Divi's Laboratories Ltd. is Rs 7305 as of 24 July 2026.

What is the Market Capitalization of Divi's Laboratories Ltd. ?

The current market cap of Divi's Laboratories Ltd. is undefined Market capitalisation is calculated by multiplying the current share price with the total number of shares.

What are the PE and PB ratios of Divi's Laboratories Ltd.?

Divi's Laboratories Ltd. has a price-to-earnings (PE) ratio of undefined and a price-to-book (PB) ratio of undefined.

What is the 52-week high/low of Divi's Laboratories Ltd.?

The 52-week high of Divi's Laboratories Ltd. is Rs 7438.5 and the 52-week low is Rs 3350
Hero Img
Join 10,00,000 Indian traders and discuss trades, strategies, news & views on any stock.
Create your account on Frontpage
DisclaimerPrivacy
FrontPage © 2026